"Designing Growth Strategies is in our DNA"

Heparin Market Size, Share & COVID-19 Impact Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics), and Regional Forecast, 2020-2027

Region : Global | Format: PDF | Report ID: FBI104447

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    2. New Product Launches
    3. Prevalence of Key Cardiovascular Diseases, By Key Countries
    4. China Heparin Market Overview
    5. Blood Clots: Stats & Facts
    6. Overview of Technological Advancements in Heparin
    7. Impact of COVID-19 on the Global Heparin Market
    8. Regulatory Scenario by Key Countries
    9. Reimbursement Scenario by Key Countries
    10. Trends of Heparin Consumption in Muslim-oriented Markets
    11. Insights on Usage of Unfractionated Heparin (UFH) & Low Molecular Weight Heparin (LMWH)
    12. China Heparin Market Overview (Production/ Supply Impacted by Swine Fever, etc.)
    13. Purchasing Process – Heparin
    14. Pricing of Heparin
  5. Global Heparin Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Heparin Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis – By Country
      1. U.S.
      2. Canada
    8. U.S. Heparin Market Analysis, Insights and Forecast, 2016-2027
      1. Key Findings / Summary
      2. Market Analysis – By Product
        1. Unfractionated Heparin (UFH)
        2. Low Molecular Weight Heparin (LMWH)
      3. Market Analysis – By Source
        1. Bovine
        2. Porcine
      4. Market Analysis – By Application
        1. Deep Vein Thrombosis & Pulmonary Embolism
        2. Atrial Fibrillation
        3. Heart Attacks
        4. Stroke
        5. Others
      5. Market Analysis, Insights and Forecast – By Route of Administration
        1. Intravenous Infusion
        2. Subcutaneous Injection
      6. Market Analysis – By End User
        1. Hospitals & ASCs
        2. Clinics
        3. Others
  7. Europe Heparin Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Heparin Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Heparin Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2019)
    2. Comparative Analysis – Major Players
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Opocrin S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Baxter
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bioiberica S.A.U.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Fresenius SE & Co. KGaA
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. B. Braun Melsungen AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. LEO Pharma A/S
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Aspen Holdings
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

List of Figures:

Figure 01: Global Heparin Market Revenue Breakdown (US$ Bn, %) by Region, 2019 & 2027

Figure 02: Global Heparin Market Value Share (%), By Product Type, 2019 & 2027

Figure 03: Global Heparin Market Value Share (%), By Source, 2019 & 2027

Figure 04: Global Heparin Market Value Share (%), By Application, 2019 & 2027

Figure 05: Global Heparin Market Value Share (%), By Route of Administration, 2019 & 2027

Figure 06: Global Heparin Market Value Share (%), By End User, 2019 & 2027

Figure 07: Global Heparin Market Value (US$ Mn), By Region, 2019 & 2027

Figure 08: North America Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 09: North America Heparin Market Value Share (%), By Product Type, 2019

Figure 10: North America Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 11: North America Heparin Market Value Share (%), By Source, 2019

Figure 12: North America Heparin Market Value (US$ Mn), By Country, 2019 & 2027

Figure 13: North America Heparin Market Value Share (%), By Country, 2019

Figure 14: U.S. Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 15: U.S. Heparin Market Value Share (%), By Product Type, 2019

Figure 16: U.S. Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 17: U.S. Heparin Market Value Share (%), By Source, 2019

Figure 18: U.S. Heparin Market Value (US$ Mn), By Application, 2019 & 2027

Figure 19: U.S. Heparin Market Value Share (%), By Application, 2019

Figure 20: U.S. Heparin Market Value (US$ Mn), By Route of Administration, 2019 & 2027

Figure 21: U.S. Heparin Market Value Share (%), By Route of Administration, 2019

Figure 22: U.S. Heparin Market Value (US$ Mn), By End User, 2019 & 2027

Figure 23: U.S. Heparin Market Value Share (%), By End User, 2019

Figure 24: Europe Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 25: Europe Heparin Market Value Share (%), By Product Type, 2019

Figure 26: Europe Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 27: Europe Heparin Market Value Share (%), By Source, 2019

Figure 28: Asia Pacific Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 29: Asia Pacific Heparin Market Value Share (%), By Product Type, 2019

Figure 30: Asia Pacific Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 31: Asia Pacific Heparin Market Value Share (%), By Source, 2019

Figure 32: Latin America Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 33: Latin America Heparin Market Value Share (%), By Product Type, 2019

Figure 34: Latin America Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 35: Latin America Heparin Market Value Share (%), By Source, 2019

Figure 36: Middle East & Africa Heparin Market Value (US$ Mn), By Product Type, 2019 & 2027

Figure 37: Middle East & Africa Heparin Market Value Share (%), By Product Type, 2019

Figure 38: Middle East & Africa Heparin Market Value (US$ Mn), By Source, 2019 & 2027

Figure 39: Middle East & Africa Heparin Market Value Share (%), By Source, 2019

List of Tables:

Table 01: Global Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016 - 2027

Table 02: Global Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016 - 2027

Table 03: Global Heparin Market Revenue (US$ Mn) Forecast, By Application, 2016 - 2027

Table 04: Global Heparin Market Revenue (US$ Mn) Forecast, By Route of Administration, 2016 - 2027

Table 05: Global Heparin Market Revenue (US$ Mn) Forecast, By End User, 2016 - 2027

Table 06: Global Heparin Market Revenue (US$ Mn) Forecast, by Region, 2016-2027

Table 07: North America Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 08: North America Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

Table 09: North America Heparin Market Revenue (US$ Mn) Forecast, By Country, 2016-2027

Table 10: U.S. Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 11: U.S. Heparin Market Volume (Billion Units) Forecast, By Product Type, 2016-2027

Table 12: U.S. Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

Table 13: U.S. Heparin Market Revenue (US$ Mn) Forecast, By Application, 2016-2027

Table 14: U.S. Heparin Market Revenue (US$ Mn) Forecast, By Route of Administration, 2016-2027

Table 15: U.S. Heparin Market Revenue (US$ Mn) Forecast, By End User, 2016-2027

Table 16: Europe Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 17: Europe Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

Table 18: Asia Pacific Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 19: Asia Pacific Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

Table 20: Latin America Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 21: Latin America Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

Table 22: Middle East & Africa Heparin Market Revenue (US$ Mn) Forecast, By Product Type, 2016-2027

Table 23: Middle East & Africa Heparin Market Revenue (US$ Mn) Forecast, By Source, 2016-2027

 class=
  • Dec, 2020
  • 2019
  • 2016-2018
  • 135

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X